l-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor, PAF), (1.9 pmol) was prepared from the total lipid extract of the protozoan Tetrahymena pyriformis 9xlO 7 cells. The procedure involved mild alkaline hydrolysis of the total lipids, followed by acetylation and purification of the product by preparative TLC and HPLC. The yield was 60% with respect to the content of l-0-alkyl-2-acyl-sn-glyceryl-3-phosphorylcholine in the total lipids, determined after preparative TLC. The alkyl side chain of the semisynthetic PAF was composed of hexadecyl residue. Our product was identified as PAF according to its biological activity, the chromatographic behaviour on TLC and HPLC, the physicochemical properties and the behaviour under treatment with PLA2 and Lipase from Rhizopus arrhizus. The above procedure is proposed as a facile, inexpensive and convenient method.
Introduction
Platelet activating factor (PAF), the potent mediator in inflammatory and allegric reactions with an impressive spectrum of potency [ 
1-4], has been identified as l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine [5-8].
Several methods for semisynthetic preparation of PAF have been described starting from bovine heart [5, 7] , which produce PAF having mainly an octadecyl alkyl-chain [8] . Also, from ratfish liver oil [9] , a mixture of platelet activating factors containing different alkyl-chains, is obtained. Procedures including multiple steps have been previously used for the total synthesis of pure PAF [10, 11] or racemic mixtures [12, 13] .
Here, we report a facile method for the semisynthetic preparation of PAF involving mild alkaline hydrolysis and acetylation of the total lipids of the protozoan Tetrahymena pyriformis, which contain
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Materials and Methods

Materials
Bovine heart-derived PAF was a gift of Dr. C. A. Demopoulos. l-0-(hexadecyl-l',2'-3 H)-2-acetyl-snglyceryl-3-phosphorylcholine (59.5 Ci/mmol) was purchased from Dupont (U.S.A.), and 1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine was purchased from Bachem (Switzerland). Standard lipids, bovine serum albumin, phosphocreatine and phosphocreatine kinase were obtained from Sigma. "Pro-analysis" and "HPLC grade" solvents were products of Fluka (Switzerland). Proteose-peptone was purchased from Oxoid (England) and yeast extract from Merck. Sodium pentobarbital (Nembutal) was a product of Abbot. Acetyl-salicylic acid as a lysine soluble salt was a product of Galenica (Athens, Greece). Phospholipase A 2 was prepared from pig pancreas (Boehringer Ingelheim). Lipase from Rhizopus arrhizus and standard phospholipids were products of Sigma (St. Louis, U.S.A.). 
Culture conditions and lipid extraction
Determination of gly eery I-ether content of phosphatidylcholine fraction
The phospholipid classes were separated by pre- 
Characterization of PAF
Biological tests
In vitro, the biological activity of the purified semisynthetic PAF, bovine heart derived PAF and PAF (alkyl chain, C I6 ) was determined from the aggregation of ASA treated washed rabbit platelets, prepared according to the method of Ardlie 
Results
Starting from 9 x 10
7 Tetrahymena pyriformis cells containing 207 mg protein and 38.7 pmol of total lipid phosphorus, we were able to prepare 1.9 pmol of semisynthetic PAF.
The yield of the semisynthetic procedure described was calculated on the basis of lipid phosphorus determinations, after preparative TLC purification. 38.7 pmol of total lipid phosphorus were found to contain 7.2 pmol of phosphatidylcholine of which 3.2 pmol were its glyceryl-ether analog. Therefore the yield of the semisynthetic product was 60% with respect to the content of the glyceryl-ether analog of phosphatidylcholine.
The semisynthetic product isolated by preparative TLC gave seven distinct peaks in normal phase silica HPLC (Fig. la) . The biologically active fractions (purified PAF) were eluted with a retention time of 24 min, identical to that of [ 3 H] PAF (Fig. 1 b) . Since the peak areas recorded by the UV detector depend on the degree of unsaturation, as well as on other absorbing functional groups (32), the semisynthetic PAF quantified by phosphorus analysis was found to contain 93% of the lipid phosphorus submitted to HPLC purification. The alkyl chain analysis of the purified product showed that the semisynthetic PAF obtained by the present method was at least 95% the hexadecyl derivative (Fig. 2) . The hypotensive response of Wistar rats to semisynthetic PAF was found to be similar to that of bovine heart-derived PAF (Table I ).
The semisynthetic PAF and the bovine heart-derived PAF were completely inactivated after treatment with 0.5 N NaOH in methanol or PLA 2 but was almost resistant after incubation with lipase from Rhizopus arrhizus or treatment with 4 N HCl (Table II) . [14] and the natural occurrence of PAF in its lipids has also been reported [33] . Our method has a very good yield, reaching the 60% of the glyceryl ether analog of PC content of the cell.
Discussion
The alkyl chain analysis of our semisynthetic PAF has shown that its alkyl side chain is composed of hexadecyl residue. It is well established that the alkyl chain length plays an important role in the biological activity of PAF, the hexadecyl-analog being the more potent [32] . In agreement to this, the biological activity of our PAF on washed rabbit platelets was found threefold more potent than that of the bovine heart-derived, which contains mainly the octadecyl residue. Therefore, the availability PAF (alkyl chain; C 16 ) easily prepared by the present procedure would allow its beneficial use in biochemical and physiological experiments, especially in binding studies. On the other hand, for studying the biochemical effects of PAF on the protozoan, it would be more convenient to use the Tetrahymena pyriformis-derived PAF, which most probably has the same structure as the protozoans native PAF.
Our method compaired to others is more rapid and very facile, since the starting material is easily available and no special laboratory equipment (e.g. for hydrogénation) is required. Therefore, the procedure can be easily reproduced in every biochemical laboratory.
